$BZFD Cashflow Statement | Understand Stock

$BZFD

$0.95 +$0.01 (0.61%) Close

$BZFD Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Operating activities:
Net loss
Less: net (income) loss from discontinued operations, net of tax
Net loss from continuing operations
Adjustments to reconcile net loss from continuing operations to cash used in operating activities:
Depreciation and amortization
Unrealized gain on foreign currency
Stock-based compensation
Change in fair value of warrants
Change in fair value of derivative liability
Issuance costs allocated to derivative liability
Amortization of debt discount and deferred issuance costs
Deferred income tax
Loss on disposition of subsidiaries
Loss (gain) on disposition of assets
Loss on extinguishment of debt
Loss on investment
Provision for doubtful accounts
Impairment expense
Noncash lease expense
Changes in operating assets and liabilities:
Accounts receivable
Prepaid expenses and other current assets and prepaid expenses and other assets
Film costs
Accounts payable
Deferred rent
Accrued compensation
Accrued expenses, other current liabilities, and other liabilities
Lease liabilities
Deferred revenue
Cash used in operating activities from continuing operations
Cash used in operating activities from discontinued operations
Cash used in operating activities

Investing activities:
Capital expenditures
Capitalization of internal-use software
Business combinations, net of cash acquired
Proceeds from sale of assets
Cash of disposed subsidiaries, less proceeds on disposition
Cash used in investing activities from continuing operations
Cash provided by investing activities from discontinued operations
Cash (used in) provided by investing activities
Financing activities:
Proceeds from reverse recapitalization, net of costs
Proceeds from issuance of common stock
Borrowings from Term Loan
Borrowings from film financing arrangements
Repayments on secured borrowing facility
Proceeds from co-financing arrangements for feature films
Borrowings on revolving credit facility
Payment on Convertible Notes
Payment of consent solicitation fees
Payment of film financing arrangements for feature films
Payment on revolving credit facility
Payment of early termination fee for revolving credit facility
Payment of Term Loan's debt issuance costs
Repurchase of common stock
Proceeds from exercise of stock options
Payment for shares withheld for employee taxes
Deferred reverse recapitalization costs
Proceeds from issuance of convertible notes, net of issuance costs
Proceeds from the issuance of common stock in connection with the at-the-market offering, net of issuance costs
Distributions to noncontrolling interests
Cash provided by (used in) financing activities

Effect of currency translation on cash and cash equivalents
Net (decrease) increase in cash and cash equivalents
Cash paid for income taxes, net
Cash paid for interest
Cash and cash equivalents and restricted cash at beginning of year
Cash and cash equivalents and restricted cash at end of year

Comments